Cargando…
Early Experience with the New XEN63 Implant in Primary Open-Angle Glaucoma Patients: Clinical Outcomes
The new XEN63 implant is a minimally invasive glaucoma surgery device with limited experience in real life. This retrospective study included open-angle glaucoma patients who underwent XEN63 implant, either alone or in combination with cataract surgery. Primary endpoints were the intraocular pressur...
Autores principales: | Fea, Antonio Maria, Menchini, Martina, Rossi, Alessandro, Posarelli, Chiara, Malinverni, Lorenza, Figus, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069200/ https://www.ncbi.nlm.nih.gov/pubmed/33921311 http://dx.doi.org/10.3390/jcm10081628 |
Ejemplares similares
-
Outcomes of XEN 63 Device at 18-Month Follow-Up in Glaucoma Patients: A Two-Center Retrospective Study
por: Fea, Antonio Maria, et al.
Publicado: (2022) -
Italian Candidates for the XEN Implant: An Overview from the Glaucoma Treatment Registry (XEN-GTR)
por: Posarelli, Chiara, et al.
Publicado: (2022) -
XEN(®) Gel Stent: A Comprehensive Review on Its Use as a Treatment Option for Refractory Glaucoma
por: Fea, Antonio M, et al.
Publicado: (2020) -
XEN Gel Stent in the management of primary open-angle glaucoma
por: Post, Michał, et al.
Publicado: (2020) -
Combined Phacoemulsification and Ex-PRESS Implant with Everting Suture in Primary Angle-Closure Glaucoma: Survival Analysis and Predictive Factors
por: Covello, Giuseppe, et al.
Publicado: (2021)